Company Name: |
J & K SCIENTIFIC LTD.
|
Tel: |
010-82848833 400-666-7788 |
Email: |
jkinfo@jkchemical.com |
Products Intro: |
Product Name:BLI 489 Hydrate CAS:623564-40-9 Package:100Mg,10Mg
|
Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Email: |
orderCN@merckgroup.com |
Products Intro: |
Product Name:BLI-489 CAS:623564-40-9 Purity:>=98% (HPLC) Package:5mg, 25mg Remarks:PZ0022
|
|
| (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate Basic information |
Product Name: | (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate | Synonyms: | (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate;BLI 489 Hydrate;WAY-185489;6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt hydrate | CAS: | 623564-40-9 | MF: | C13H12N3NaO5S | MW: | 345.30625 | EINECS: | | Product Categories: | Heterocycles;Intermediates & Fine Chemicals;Pfizer Compounds;Pharmaceuticals;Sulfur & Selenium Compounds | Mol File: | 623564-40-9.mol | |
| (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate Chemical Properties |
Melting point | >200°C (dec.) | storage temp. | room temp | solubility | H2O: >20mg/mL | form | powder, yellow | color | Yellow |
| (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate Usage And Synthesis |
Chemical Properties | Yellow Solid | Uses | BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria. | Biochem/physiol Actions | BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria. |
| (5R,6Z)-6-[(5,6-Dihydro-8H-iMidazo[2,1-c][1,4]oxazin-2-yl)Methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid SodiuM Salt Hydrate Preparation Products And Raw materials |
|